SGPGIMS gets Australian patent for study on steroid toxicity

SGPGIMS


Lucknow, Nov 10 : The Australian government has awarded an international patent to the nephrology department of Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) for innovation in management of common renal disease in children called nephrotic syndrome. According to Prof Narain Prasad, head of nephrology department at SGPGI: "As a result of the disease, children lose heavy amount of protein in the urine and swelling appears all over the body. Gradually, it may lead to kidney failure, requiring dialysis and renal transplantation. The treatment for this disease rests on steroid, but while some children are resistant to steroids since the beginning, many develop resistance during treatment." At least 8,000 cases of this common renal disease are reported at SGPGI alone each year and about 10-20 per cent of children do not respond to steroid therapy. Nearly one-third of the remaining 80 per cent develop steroid resistance after initial response, while another proportion develop it in the later stages. Prasad said that prolonged resistance to steroid leads to a kind of toxicity in the body, which pre-disposes them to infections, weakens their immunity, results in stunted growth, produces bone weakness, many metabolic conditions like diabetes and cataract. "The challenges became the base for research and evolved into an innovation, which earned the Australian patent. Valid for eight years, the patented method recognised new biomarkers -- called P-gp and MRP-1 in this case -- to identify steroid resistance so that the alternative regimen may be introduced," said Prasad. He said that in case of resistance, the body treats steroid like a foreign substance and triggers release of glycoproteins P-gp and MRP-1. These proteins on the body cell surface work like an efflux pump and bloat to prevent penetration of the medicine inside. As a result, the medicine does not work and the symptoms show up. The puffiness goes up further as the medicine does not act. Prasad said that exposing children to tests to determine P-gp and MRP-1 levels in blood can help. He said the study establishing the success of the method has been published in high impact medical journal Nature's publication Pharmacogenomics. /IANS




Related

Karnataka logs 34,041 new Covid cases
Bengaluru, Jan 16 : Karnataka on Sunday logged 34,047 new Covid cases taking the number of active cases in the state to 1,97,982, while there were fre

India's vax prog is a role model for global community: Mandaviya
New Delhi, Jan 16 : Union Health Minister Mansukh Mandaviya on Sunday said that India's vaccination programme is "in fact" a role model for the global

Delhi reports 18,286 fresh Covid cases, 28 deaths
New Delhi, Jan 16 : Delhi on Sunday recorded 18,286 new Covid cases, a slight dip for the third consecutive day, taking its tally to 17,09,870, while